ALLOZYNE INC
Biotechnology · Seattle, WA
Bayanan rajista na hukuma
0masu bi
2005an kafa
Game da ALLOZYNE INC
Allozyne was a clinical stage biotechnology company headquartered in Seattle's biotech and high tech innovation corridor. Allozyne was founded in 2005 by California Institute of Technology researchers, and was incubated by Accelerator Corporation. Its lead product candidate, AZ01, is a long acting interferon beta for the treatment of the relapsing remitting form of multiple sclerosis, a chronic degenerative disease characterized by demyelination of nerve fibers leading to severe nerve damage and increasing disability. Multiple sclerosis is estimated to affect 400,000 individuals in the US alone and 2.5 million worldwide. AZ01 is currently undergoing Phase I clinical trials in the US. Preclinical data indicates that AZ01 has the potential to be dosed once monthly compared to the current standard of care dosed anywhere from once daily to once per week.
Source: Wikipedia
Masana'antuBiotechnology
HedikwataSeattle, WA
An kafa2005
Nau'in dokaC Corporation
MatsayiMai aiki
Bitoci
Babu bitoci tukuna. Ka yi aiki da ALLOZYNE INC? Kasance na farko da zai raba gogewarsa.
Muhimman lambobi
Shiga don ganin lambobi masu mahimmanci
Kudaden shiga, ribar ƙarshe da yawan ma'aikata na ALLOZYNE INC a cikin shekaru, tare da tushensu.
Shiga Ƙirƙiri asusu da imel ɗinkuKyauta ne
Idan kuka ci gaba, kuna yarda da Yarjejeniyar mai amfani, Manufar sirri da Manufar kukis na Heelky.
Bayanan doka
| Sunan doka | ALLOZYNE INC |
|---|---|
| Nau'in doka | C Corporation |
| SEC CIK | 1345630Duba a SEC EDGAR ↗ |
| Adireshin da aka yi rajista | Seattle, WA |
| Matsayi | Mai aiki |
Tushe: SEC EDGAR · an sabunta Nov. 14, 2026
Tuntuɓa & hanyoyin haɗi
Wuri
Seattle, WA
Wannan kamfaninka ne?
Yi da'awar wannan shafi kyauta don ƙara tambari, kayayyaki, hotuna da ayyuka, da amsa bitoci.
Yi da'awar wannan shafiShiga Heelky don haɗuwa, ɗaukar ma'aikata da haɓaka
Ƙirƙiri asusu kyauta don aika wa mutane saƙo, neman ayyuka da wallafa kwangiloli.
Shiga yanzu — kyauta ne